Rules-Based Medicine Gets Award to Develop Cancer Biomarker Assays
July 06, 2010
Rules-Based Medicine Gets Award to Develop Cancer Biomarker Assays
The $3 million award will go toward developing and validating multiplexed immunoassays that measure 150 to 180 blood-based biomarkers that the National Cancer Institute believes may be associated with cancer.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- CPRIT Awards RBM $3M to Expand OncologyMAP Biomarker Panel; Launch Targeted for Fall
July 16, 2010 / ProteoMonitor - Cancer Genetics Files for $15M Stock Offering
June 6, 2013 / GenomeWeb Daily News - Genomics Experts at ASCO Weigh in on Strategies for TCGA Translation
June 3, 2013 / GenomeWeb Daily News - CGI Pledges to Launch Two More Array Tests This Year after 'Busy' Q1
May 28, 2013 / BioArray News - Kindstar to Offer Illumina's Infinium Dx CytoSNP-12 BeadChip in China
April 23, 2013 / BioArray News